Physician profile
Anne Carter
NPI 1982704987
$528.52
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $202 · 2021: $193 · 2022: $24.80.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $188.62 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $103.12 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.89 | 2020-2021 | |
| Radius Health, INC. | $52.37 | 2020-2021 | |
| Abbott Laboratories | $39.65 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $35.23 | 2019 | |
| Bioventus LLC | $23.97 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $20.04 | 2021 | |
| Pfizer INC. | $11.63 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.